PUBLISHER: iData Research Inc. | PRODUCT CODE: 1328964
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1328964
In 2022, the European market for infusion therapy devices achieved a valuation of $1.1 billion. Over the forecast period, it is expected to experience significant growth, reaching a value of at least €1.3 billion by 2029.
This medical market research involved a thorough analysis of 46 infusion therapy companies operating across Europe. Through our comprehensive methodology, we obtained insights into market sizes, unit sales, company market shares, and created accurate forecasts.
The full report suite on the European market for infusion therapy devices comprises six categories: infusion pumps, intravenous (IV) sets, needleless connectors (NLCs), IV filters, stopcocks, and blood transfusion sets. Each category is further segmented based on specific distinguishing factors. The infusion pump market is segmented by the type of infusion performed, including large-volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, electronic ambulatory pumps, and disposable ambulatory pumps. Each pump sub-segment is also further segmented by care setting. The IV set market is segmented based on tubing type, such as pump IV sets, gravity IV sets, secondary IV sets, and IV extension sets. Each type of IV set is also segmented by care setting. The needleless connector market is segmented by displacement type, including negative, positive, neutral, and anti-reflux neutral displacement connectors. Additionally, it is segmented by device type (standalone and integrated) and care setting.
The growing elderly population in Europe is a major driver for the infusion therapy device market. With the aging population, there is an increased need for frequent and chronic treatments, leading to a rise in demand for infusion therapy devices. This trend is expected to fuel the growth of both the disposable and capital equipment markets, resulting in an increase in unit sales during the forecast period. The growing need for these devices in chronic treatment settings further contributes to the market's expansion.
Over the past five years, European countries have shown a significant trend towards rapid adoption of needleless connectors in the market. This growing interest can be attributed to the numerous advantages offered by these connectors. One key benefit is the improved patient safety they provide by reducing the risk of needlestick injuries and associated infections. Additionally, needleless connectors enhance convenience and efficiency by enabling easier access and administration of medications, thus reducing the need for multiple needle insertions. These advantages have played a pivotal role in driving the widespread adoption of needleless connectors across Europe.
In 2022, B. Braun emerged as the leading competitor in the European infusion therapy device market. The company achieved significant revenues in the IV set and infusion pump markets, while also leading the market for stopcocks. B. Braun's ability to offer a comprehensive range of infusion therapy products and cater to diverse consumer needs has contributed to its strong market position. Becton Dickinson secured the second position as a leading competitor in the European infusion therapy device market in 2022. The company was involved in various segments of the market covered in this report and demonstrated particular strength in the needleless connector market. Fresenius Kabi ranked third among the top competitors in the European infusion therapy device market. The company has experienced notable growth attributed to its lower manufacturing costs, enabling hospitals and group purchasing organizations (GPOs) to benefit from lower prices.
Throughout this research series, iData Research has covered several countries in great detail. The countries covered are:
|
|
Feel free to click on each title to view detailed market segmentation. Please note that the analysis of each of the Infusion Therapy market segments can be purchased as separate reports, MedCores.
List of Charts
List of Figures